Cancer Prevention and Control Recent Publications

• [Retracted] MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.Han R, Zhao J, Lu L. Oncol Rep. 2025 Jan; 2024 Nov 14. PMID: 39540400.
• Use of cannabis among youth who vape nicotine.Davis DR, Bold KW, Wu R, Morean ME, Kong G, Krishnan-Sarin S. Addict Behav. 2025 Jan; 2024 Sep 22. PMID: 39326231.
• Asparagine synthetase and G-protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer.Lu L, Zhang Q, Aladelokun O, Berardi D, Shen X, Marin A, Garcia-Milian R, Roper J, Khan SA, Johnson CH. Int J Cancer. 2025 Jan 1; 2024 Jul 22. PMID: 39039782.
• Construction and performance of a clinical prediction rule for ureteral stone without the use of race or ethnicity: A new STONE score.Moore CL, Gross CP, Hart L, Molinaro AM, Rhodes D, Singh D, Baloescu C. J Am Coll Emerg Physicians Open. 2024 Dec; 2024 Nov 7. PMID: 39524039.
• A landmark federal interagency collaboration to promote data science in health care: Million Veteran Program-Computational Health Analytics for Medical Precision to Improve Outcomes Now.Justice AC, McMahon B, Madduri R, Crivelli S, Damrauer S, Cho K, Ramoni R, Muralidhar S. JAMIA Open. 2024 Dec; 2024 Nov 6. PMID: 39507405.
• Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy.Huntington SF, Lin D, Lafeuille MH, Thompson-Leduc P, Shah A, Kim N, Hester L, Tardif-Samson A, Moore B, Fowler J, Marshall A, Zhang X, Gifkins D, Wu B. Pharmacol Res Perspect. 2024 Dec. PMID: 39487576.
• Anxiety and fear of cancer recurrence as predictors of subsequent pain interference in early cancer survivorship: Exploring the moderating roles of cognitive and emotional factors.Gnall KE, Emrich M, Magin ZE, Park CL, Bellizzi KM, Sanft T. J Behav Med. 2024 Dec; 2024 Aug 7. PMID: 39110352.
• Smartband-based smoking detection and real-time brief mindfulness intervention: findings from a feasibility clinical trial.Horvath M, Pittman B, O'Malley SS, Grutman A, Khan N, Gueorguieva R, Brewer JA, Garrison KA. Ann Med. 2024 Dec; 2024 Jun 1. PMID: 38823419.
• A gap analysis of UK biobank publications reveals SNPs associated with intrinsic subtypes of breast cancer.van den Driest L, Kelly P, Marshall A, Johnson CH, Lasky-Su J, Lannigan A, Rattray Z, Rattray NJW. Comput Struct Biotechnol J. 2024 Dec; 2024 May 10. PMID: 38817965.
• Development and initial testing of mindful journey: a digital mindfulness-based intervention for promoting recovery from Substance use disorder.Roos CR, Kiluk B, Carroll KM, Bricker JB, Mun CJ, Sala M, Kirouac M, Stein E, John M, Palmer R, DeBenedictis A, Frisbie J, Haeny AM, Barry D, Fucito LM, Bowen S, Witkiewitz K, Kober H. Ann Med. 2024 Dec; 2024 Feb 21. PMID: 38382111.
• Alcohol use and cannabis craving in daily life: Sex differences and associations among young adults.Davis CN, Ramer NE, Squeglia LM, Gex KS, McRae-Clark AL, McKee SA, Roberts W, Gray KM, Baker NL, Tomko RL. Alcohol Clin Exp Res (Hoboken). 2024 Nov 23; 2024 Nov 23. PMID: 39579151.
• Development and Psychometric Evaluation of a Novel Measure of Nicotine E-cigarette Withdrawal for Use With Adolescents and Young Adults.Morean ME, Rajeshkumar L, Krishnan-Sarin S. Nicotine Tob Res. 2024 Nov 22. PMID: 38695371.
• Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020.Ajjawi I, Loeb S, Cooperberg MR, Catalona WJ, Gross CP, Ma X, Leapman MS. JAMA. 2024 Nov 20; 2024 Nov 20. PMID: 39565605.
• Ethical issues in implementation science: perspectives from a National Heart, Lung, and Blood Institute workshop.Dickert NW, Spiegelman D, Blumenthal-Barby JS, Graham G, Joffe S, Kahn JM, Kass NE, Kim SYH, Kerlin MP, Langford AT, Lavery JV, Matlock DD, Fenton KN, Mensah GA. Implement Sci. 2024 Nov 19; 2024 Nov 19. PMID: 39563405.
• Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2-mutant refractory/relapsed AML.Alhajahjeh A, Patel KK, Shallis RM, Podoltsev NA, Kewan T, Stempel JM, Mendez L, Huntington SF, Stahl M, Goshua G, Bewersdorf JP, Zeidan AM. Leuk Lymphoma. 2024 Nov 19; 2024 Nov 19. PMID: 39560957.
• Association Between Environmental Air Pollution and Thyroid Cancer and Nodules: A Systematic Review.Vohra V, Yesantharao LV, Stemme R, Seal SM, Morris-Wiseman LF, McAdams-DeMarco M, Mady LJ, Deziel NC, Biswal S, Ramanathan M Jr, Mathur A. Thyroid. 2024 Nov 18; 2024 Nov 18. PMID: 39552469.
• The longitudinal association between resilience and sleep quality in breast cancer.Li S, Mai Q, Mei X, Jiang Y, Xiong Y, Zeng Y, Knobf MT, Ye Z. Eur J Oncol Nurs. 2024 Nov 15; 2024 Nov 15. PMID: 39571333.
• Correction: Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study.Bade BC, Gan G, Li F, Lu L, Tanoue L, Silvestri GA, Irwin ML. BMC Cancer. 2024 Nov 15; 2024 Nov 15. PMID: 39548453.
• Supporting diversity in clinical trials: the equitable breakthroughs in medicine site maturity model.Harris T, Nunez-Smith M, Suttiratana SC, Fretz SL, Leonard S, Linnander E, Curry LA. Trials. 2024 Nov 14; 2024 Nov 14. PMID: 39543751.
• Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, Qualls D, Amoozgar B, Kahl B, Baird J, Challa P, Huntington SF, Santos J, Bair S, Narkhede M, Li S, Frosch Z, Ho C, Smith SD, Winter A, Landsburg D, Furqan F, Hamadani M, Baird K, Romancik J, Alharthy H, Law J, Bojanini L, Advani R, Hu B, Johnson PC, Grover NS, Merril M, Crombie JL, Shafagati N, Sterling C, Nastoupil LJ, Epperla N, Ayers EC. Haematologica. 2024 Nov 14; 2024 Nov 14. PMID: 39540227.
• Phosphatidylethanol Can Improve Detection and Treatment of Unhealthy Alcohol Use.Hahn JA, Piano MR, Hwang CL, Justice AC. Am J Prev Med. 2024 Nov 13; 2024 Nov 13. PMID: 39547265.
• OncoSexome: the landscape of sex-based differences in oncologic diseases.Shen X, Zhang Y, Li J, Zhou Y, Butensky SD, Zhang Y, Cai Z, DeWan AT, Khan SA, Yan H, Johnson CH, Zhu F. Nucleic Acids Res. 2024 Nov 13; 2024 Nov 13. PMID: 39535034.
• Recommendations for Clinicians, Technologists, and Healthcare Organizations on the Use of Generative Artificial Intelligence in Medicine: A Position Statement from the Society of General Internal Medicine.Crowe B, Shah S, Teng D, Ma SP, DeCamp M, Rosenberg EI, Rodriguez JA, Collins BX, Huber K, Karches K, Zucker S, Kim EJ, Rotenstein L, Rodman A, Jones D, Richman IB, Henry TL, Somlo D, Pitts SI, Chen JH, Mishuris RG. J Gen Intern Med. 2024 Nov 12; 2024 Nov 12. PMID: 39531100.
• Financial Compensation of Academic Otolaryngologists in the United States: Trends and Distribution.Shah R, Tyagi S, Futela D, Malhotra A, Judson BL. Laryngoscope. 2024 Nov 12; 2024 Nov 12. PMID: 39530275.
• ASO Visual Abstract: Living Flat-Stories from Women of Color After Mastectomy.Khubchandani JA, Suttiratana SC, Washington R, White-Bracey D, Kc M, Silber A, Fayanju OM, Butler PD, Menon A, Greenup RA. Ann Surg Oncol. 2024 Nov 12; 2024 Nov 12. PMID: 39528648.
• Baseline predictors associated with successful weight loss among breast cancer survivors in the Lifestyle, Exercise, and Nutrition (LEAN) study.Hoobler R, Puklin LS, Harrigan M, Cartmel B, Li FY, Sanft T, Ferrucci LM, Irwin ML, Playdon MC. J Cancer Surviv. 2024 Nov 11; 2024 Nov 11. PMID: 39528779.
• The Association Between Medical Insurance, Access to Care, and Outcomes for Patients with Uveal Melanoma in the United States.Marks VA, Williams BK Jr, Leapman MS, Shields CL. Semin Ophthalmol. 2024 Nov 9; 2024 Nov 9. PMID: 39520301.
• Pathologic prostate cancer grade concordance among high-resolution micro-ultrasound, systematic transrectal ultrasound and MRI fusion biopsy.Lokeshwar SD, Choksi AU, Smani S, Kong V, Sundaresan V, Sutherland R, Brito J, Renzulli JF, Sprenkle PC, Leapman MS. Urol Oncol. 2024 Nov 8; 2024 Nov 8. PMID: 39521675.
• Use of Hospice and End-of-Life Care Quality Among Medical Centers with High Versus Lower Specialist Palliative Care Reach Among People with Heart Failure: An Observational Study.Feder SL, Han L, Zhan Y, Abel EA, Akgün KM, Fried T, Ersek M, Redeker NS. J Palliat Med. 2024 Nov 8; 2024 Nov 8. PMID: 39515377.
• Domestic groundwater wells in Appalachia show evidence of low-dose, complex mixtures of legacy pollutants.Bugher NA, Xiong B, Gentles RI, Glist LD, Siegel HG, Johnson NP, Clark CJ, Deziel NC, Saiers JE, Plata DL. Environ Sci Process Impacts. 2024 Nov 6; 2024 Nov 6. PMID: 39501836.
• Global trends in CD4 count measurement and distribution at first antiretroviral treatment initiation.de Waal R, Wools-Kaloustian K, Brazier E, Althoff KN, Jaquet A, Duda SN, Kumarasamy N, Savory T, Byakwaga H, Murenzi G, Justice A, Ekouevi DK, Cesar C, Pasayan MKU, Thawani A, Kasozi C, Babakazo P, Karris M, Messou E, Cortes CP, Kunzekwenyika C, Choi JY, Owarwo NC, Niyongabo A, Marconi VC, Ezechi O, Castilho JL, Petoumenos K, Johnson L, Ford N, Kassanjee R. Clin Infect Dis. 2024 Nov 6; 2024 Nov 6. PMID: 39501773.
• Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis.Ilagan-Ying YC, Gordon KS, Tate JP, Lim JK, Torgersen J, Lo Re V 3rd, Justice AC, Taddei TH. JAMA Netw Open. 2024 Nov 4; 2024 Nov 4. PMID: 39504020.
• Risk of Liver Injury With Potentially Hepatotoxic Drugs-Reply.Lo Re V 3rd, Torgersen J, Justice AC. JAMA Intern Med. 2024 Nov 4; 2024 Nov 4. PMID: 39495534.
• Disparities in Colorectal Cancer Screening Before and After the Onset of the COVID Pandemic.Siddique S, Wang R, Gaddy JJ, Stempel JM, Warren JL, Gross CP, Ma X. J Gen Intern Med. 2024 Nov 4; 2024 Nov 4. PMID: 39495455.
• County-level racial disparities in prostate cancer specific mortality from 2005 to 2020.Washington SL 3rd, Fakunle M, Wang L, Braun AE, Leapman M, Cowan JE, Cooperberg MR. JNCI Cancer Spectr. 2024 Nov 4; 2024 Nov 4. PMID: 39495143.
• The Influence of DNA Repair Genes and Prenatal Tobacco Exposure on Risk of Childhood Acute Lymphoblastic Leukemia-A Gene-Environment Interaction Study.Wang X, Zhong C, Ma X, Metayer C, Mancuso N, Gauderman WJ, Wiemels JL. Cancer Epidemiol Biomarkers Prev. 2024 Nov 4; 2024 Nov 4. PMID: 39495115.
• A multi-trait epigenome-wide association study identified DNA methylation signature of inflammation among men with HIV.Chen J, Hui Q, Titanji BK, So-Armah K, Freiberg M, Justice AC, Xu K, Zhu X, Gwinn M, Marconi VC, Sun YV. Clin Epigenetics. 2024 Nov 2; 2024 Nov 2. PMID: 39488703.
• Quantitative measures of recent and lifetime agricultural pesticide use are associated with increased pesticide concentrations in house dust.Xie S, Hofmann JN, Sampson JN, Josse PR, Madrigal JM, Chang VC, Deziel NC, Andreotti G, Keil AP, Ward MH, Beane Freeman LE, Friesen MC. Environ Int. 2024 Nov; 2024 Nov 5. PMID: 39541787.
• Autoimmune Diseases and Risk of Non-Hodgkin Lymphoma: A Mendelian Randomisation Study.Shi X, Wallach JD, Ma X, Rogne T. Cancer Med. 2024 Nov. PMID: 39506244.
• Accessing breast cancer care in a protracted conflict: Qualitative exploration of the perspectives of women with breast cancer in northwest Syria.Marzouk M, Hamze M, Debel J, Alshemali A, Alameen BA, Bakkour M, Galal B, Chagpar AB, Atassi B, Khoshnood K, Abbara A. Soc Sci Med. 2024 Nov; 2024 Sep 21. PMID: 39357306.
• Reprint of: Sex differences in appeal, reward, and sensory experience of E-cigarette flavors among adults who smoke cigarettes.Davis DR, Buta E, Green B, Krishnan-Sarin S. Prev Med. 2024 Nov; 2024 Sep 4. PMID: 39232940.
• Reply to Editorial Comment on "Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy".Rabil MJ, Leapman MS, Cavallo JA. Urology. 2024 Nov; 2024 Aug 28. PMID: 39208938.
• Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer.Sundaresan VM, Wang R, Long JB, Sprenkle PC, Seibert TM, Loeb S, Cooperberg MR, Catalona WJ, Ma X, Gross CP, Leapman MS. Urol Pract. 2024 Nov; 2024 Jul 16. PMID: 39196719.
• Parent-Clinician Communication and Prolonged Grief in Parents Whose Child Died From Cancer.Ouyang N, Baker JN, Ananth PJ, Knobf MT, Snaman JM, Feder SL. J Pain Symptom Manage. 2024 Nov; 2024 Aug 12. PMID: 39142495.
• Reply to O. Saifi et al.Yu JB, DeStephano DM, Horowitz DP, Gross CP, Cheng SK. J Clin Oncol. 2024 Nov; 2024 Jul 30. PMID: 39079081.
• COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration.Soyer EM, McGinnis KA, Justice AC, Hsieh E, Rodriguez-Barradas MC, Williams EC, Park LS. AIDS Behav. 2024 Nov; 2024 Jul 24. PMID: 39046612.
• Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy.Rabil MJ, Jalfon M, Heckscher D, Song Z, Li F, Martin T, Sprenkle PC, Hesse D, Kim IY, Leapman MS, Cavallo JA. Urology. 2024 Nov; 2024 Jul 15. PMID: 39019332.
• Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer.Foldi J, Blenman KRM, Marczyk M, Gunasekharan V, Polanska A, Gee R, Davis M, Kahn AM, Silber A, Pusztai L. Breast Cancer Res Treat. 2024 Nov; 2024 Jul 13. PMID: 39002068.
• Using phosphatidylethanol as an adjunct to self-reported alcohol use improves identification of liver fibrosis risk.Murnane PM, Afshar M, Chamie G, Cook RL, Ferguson T, Haque LY, Jacobson KR, Justice AC, Kim TW, Khalili M, Krupitsky E, McGinnis KA, Molina P, Muyindike WR, Myers B, Richards VL, So-Armah K, Stewart S, Sulkowski MS, Tien PC, Hahn JA. Am J Gastroenterol. 2024 Oct 31; 2024 Oct 31. PMID: 39480054.
• Understanding use of e-cigarettes for smoking cessation among a sample of US adults.Sharma A, Morean ME, Krishnan-Sarin S, O'Malley SS, Bold KW. Nicotine Tob Res. 2024 Oct 30; 2024 Oct 30. PMID: 39475073.
• Using a Bayesian analytic approach to identify county-level ecological factors associated with survival among individuals with early-onset colorectal cancer.Siddique S, Baum LVM, Deziel NC, Kelly JR, Warren JL, Ma X. PLoS One. 2024; 2024 Oct 29. PMID: 39471191.
• Delineating Urbanicity and Rurality: Impact on Environmental Exposure Assessment.Song Y, Deziel NC, Bell ML. Environ Sci Technol. 2024 Oct 29; 2024 Oct 16. PMID: 39412270.
• Updated CP*Trends: An Online Tool to Compare Cohort and Period Trends across Cancer Sites.Holford TR, Chen HS, Kane MJ, Krapcho M, Annett D, Esclamado L, Melkonyan A, Feuer EJ. Am J Epidemiol. 2024 Oct 28; 2024 Oct 28. PMID: 39475089.
• Novel metabolomic predictors of incident colorectal cancer in men and women.Downie JM, Joshi AD, Geraghty CM, Guercio BJ, Zeleznik OA, Song M, Bever AM, Drew DA, Tabung FK, Zhang X, Jin L, Eliassen AH, Willett WC, Wu K, Kraft P, Tamimi R, Clish C, Fuchs CS, Giovannucci E, Meyerhardt JA, Chan AT. J Natl Cancer Inst. 2024 Oct 28; 2024 Oct 28. PMID: 39468739.
• The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol.Womack JA, Leblanc MM, Sager AS, Zaets LN, Maisto SA, Garcia A, Aoun-Barakat L, Brown SE, Edelman EJ, Fiellin DA, Fisher J, Fraenkel L, Kidwai-Khan F, Marconi VC, Martino S, Pulk R, Satre DD, Virata M, Justice AC, Hsieh E. AIDS Behav. 2024 Oct 28; 2024 Oct 28. PMID: 39465468.
• Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients with Low-Risk Prostate Cancer in the Community Practice.Gaylis FD, Leapman MS, Ellis SD, Hu S, Cooperberg MR, Loeb S, Chen RC, Cohen ES, Dato PE, Aynehchi S, David R, Topp R, Santomauro B, Ginsburg K, Catalona WJ. Urol Pract. 2024 Oct 25; 2024 Oct 25. PMID: 39453985.
• 16S rRNA target sequencing of human tumors validates findings of Lachnoclostridium abundance in human melanomas that are heavily CD8+ T-cell infiltrated.Lu L, Johnson C, Khan S, Kluger H. Eur J Cancer. 2024 Oct 24; 2024 Oct 24. PMID: 39477777.
• Why do older adults stop cancer screening? Findings from the Medicare Current Beneficiary Survey.Belliveau OH, Richman IB. J Am Geriatr Soc. 2024 Oct 23; 2024 Oct 23. PMID: 39444166.
• Inter-reader reliability and diagnostic accuracy of PI-RADS scoring between academic and community care networks: How wide is the gap?Smani S, Jalfon M, Sundaresan V, Lokeshwar SD, Nguyen J, Halstuch D, Khajir G, Cavallo JA, Sprenkle PC, Leapman MS, Kim IY. Urol Oncol. 2024 Oct 21; 2024 Oct 21. PMID: 39438211.
• ASO Author Reflections: A Community Partnered Approach to Studying Living Flat After Mastectomy.Khubchandani JA, Suttiratana SC, Washington R, White-Bracey D, Kc M, Silber A, Fayanju OM, Butler PD, Menon A, Greenup RA. Ann Surg Oncol. 2024 Oct 18; 2024 Oct 18. PMID: 39424715.
• Disentangling gender, sex, and biology: a mixed methods study of gender identity data collection tools.Alpert AB, Hernandez T, Ruddick R, Manzano C, Adams S, Rivers L, Ramos-Pibernus A, Sevelius J, Poteat T, Obedin-Maliver J, Cicero EC, Radix A, Lett E, Operario D, Chapman B, Wittink M, Cupertino A, Murchison GR, Nunez-Smith M, Cartujano-Barrera F. Patient Educ Couns. 2024 Oct 16; 2024 Oct 16. PMID: 39471780.
• Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review.Fazekas T, Pallauf M, Kufel J, Miszczyk M, Tsuboi I, Matsukawa A, Laukhtina E, Kardoust Parizi M, Mancon S, Cadenar A, Schulz R, Yanagisawa T, Baboudjian M, Szarvas T, Gandaglia G, Tilki D, Nyirády P, Rajwa P, Leapman MS, Shariat SF. Eur Urol Oncol. 2024 Oct 15; 2024 Oct 15. PMID: 39414421.
• Living Flat: Stories from Women of Color After Mastectomy.Khubchandani JA, Suttiratana SC, Washington R, White-Bracey D, Kc M, Silber A, Fayanju OM, Butler PD, Menon A, Greenup RA. Ann Surg Oncol. 2024 Oct 15; 2024 Oct 15. PMID: 39407064.
• Physicians, the Homelessness Crisis, and Public Health-All Hands on Deck.Gross CP, Gluck AR, Corbie G. JAMA Intern Med. 2024 Oct 14; 2024 Oct 14. PMID: 39401048.
• Ambient Temperature and Stroke Risk Among Adults Aged 18-64 Years: A Case-Crossover Study.Chu L, Wang R, Gross CP, Chen K, Ma X. J Am Coll Cardiol. 2024 Oct 9; 2024 Oct 9. PMID: 39453364.
• Reply.Schmitz KH, Brown JC, Irwin ML, Robien K, Scott JM, Perna FM. J Natl Cancer Inst. 2024 Oct 9; 2024 Oct 9. PMID: 39383207.
• Social Support and Psychological Capital Mediate the Effect of Personalities on the Mental Health of Professional Staff in China During COVID-19 Pandemic.Yao Y, Tang J, Li Z, Chen S, Du H, Lu L. Psychol Res Behav Manag. 2024; 2024 Oct 5. PMID: 39385810.
• Diagnostic experiences of Black and White patients with uterine cancer: A qualitative study.Britton MC, Izampuye E, Clark M, Ornstein RA, Nunez-Smith M, Wright JD, Xu X. Gynecol Oncol. 2024 Oct 2; 2024 Oct 2. PMID: 39362045.
• Long-Term Outcomes of Prostate-Specific Membrane Antigen-PET Imaging of Recurrent Prostate Cancer.Kunst N, Long JB, Westvold S, Sprenkle PC, Kim IY, Saperstein L, Rabil M, Ghaffar U, Karnes RJ, Ma X, Gross CP, Wang SY, Leapman MS. JAMA Netw Open. 2024 Oct 1; 2024 Oct 1. PMID: 39441595.
• NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.Liu J, Berchuck A, Backes FJ, Cohen J, Grisham R, Leath CA, Martin L, Matei D, Miller DS, Robertson S, Barroilhet L, Uppal S, Hendrickson AW, Gershenson DM, Gray HJ, Hakam A, Jain A, Konecny GE, Moroney J, Ratner E, Schorge J, Thaker PH, Werner TL, Zsiros E, Behbakht K, Chen LM, DeRosa M, Eisenhauer EL, Leiserowitz G, Litkouhi B, McHale M, Percac-Lima S, Rodabaugh K, Vargas R, Jones F, Kovach E, Hang L, Ramakrishnan S, Alvarez RD, Armstrong DK. J Natl Compr Canc Netw. 2024 Oct. PMID: 39413835.
• USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years.Siddique S, Wang R, Yasin F, Gaddy JJ, Zhang L, Gross CP, Ma X. JAMA Netw Open. 2024 Oct 1; 2024 Oct 1. PMID: 39361285.
• Cardiomyopathy-Associated Chronic Heart Failure in Infants Aged <1 Year: A Prospective Observational Cohort Over 5 Years in Northern China.Ding W, Wang B, Hong J, Lu L, Xiao Y, Shan G, Myers C, Yu Q, Spurney C, Li Z, Han L. J Am Heart Assoc. 2024 Oct; 2024 Sep 30. PMID: 39344650.
• Associations Between Reductions in Depressive Symptoms and Reductions in Pain and Anxiety Symptoms and Substance Use: Emulation of a Randomized Trial.Khan MR, Acri M, Ban KF, Scheidell JD, Stevens ER, Manandhar-Sasaki P, Charles D, Chichetto NE, Crystal S, Gordon AJ, Marshall BDL, Edelman EJ, Justice AC, Braithwaite SR, Caniglia EC. AJPM Focus. 2024 Oct; 2024 Jul 6. PMID: 39290574.
• Barriers to Effective Infection Prevention in the Neonatal Intensive Care Unit: A Qualitative Study.Weser VU, Crocker A, Murray TS, Wright J, Truesdell EJK, Ciaburri R, Marks AM, Martinello RA, Hieftje KD. Adv Neonatal Care. 2024 Oct 1; 2024 Aug 27. PMID: 39196970.
• Evaluating Supplemental Breast Cancer Screening With Simulation Modeling.Richman IB, Battaglia TA. JAMA Intern Med. 2024 Oct 1. PMID: 39186297.
• Patterns of Physical Therapy Referral and Subsequent Attendance Among Childhood Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy at a Regional Childhood Cancer Survivorship Clinic.Kang L, Kadan-Lottick NS, Rotatori J, Kujawski SE, Messerschmidt E, Auerbach C, Balsamo LM, Lustberg MB, Ma X, Rodwin RL. Semin Oncol Nurs. 2024 Oct; 2024 Aug 19. PMID: 39164160.
• The combination of donepezil and cognitive training for improving treatment outcomes for alcohol use disorder: Design of a randomized controlled trial.Yoon G, Sofuoglu M, Petrakis IL, Pittman B, Bell MD. Contemp Clin Trials. 2024 Oct; 2024 Aug 5. PMID: 39111388.
• Design and methods of the StepByStep randomized trial of a mobile health and social media physical activity intervention among adolescent and young adult survivors of childhood cancer: A report from the Children's Oncology Group.Beight LJ, Mendoza JA, Leisenring WM, Collier W, Olsen ME, Ross WL, Santiago-Rivera Y, Bryant S, Rotatori J, Ness KK, Hurtado-de-Mendoza A, Baker KS, Chow EJ, Kadan-Lottick NS. Contemp Clin Trials. 2024 Oct; 2024 Jul 28. PMID: 39079612.
• Keeping Race and Diversity Relevant in Medical Education.Baugh AD, Akgün KM, Rusk A, Adelson VA, Afolabi F, Crowder S, Ferreira JC, Gurubhagavatula I, Lovinsky-Desir S, Lawrence K, Myers LC, Niranjan SJ, Schotland H, Sheares BJ, Sullivan DR, Wisnivesky J, Sweet SC. Ann Am Thorac Soc. 2024 Oct. PMID: 39078251.
• Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton's tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting.Huntington SF, Manzoor BS, Jawaid D, Puckett JT, Emechebe N, Ravelo A, Kamal-Bahl S, Doshi JA. J Manag Care Spec Pharm. 2024 Oct; 2024 Jul 24. PMID: 39046941.
• Real-World Treatment Patterns, Survival, and Economic Burden Among Elderly MCL Patients Previously Treated With cBTKis.Squires P, Puckett J, Ryland KE, Kamal-Bahl S, Raut M, Doshi J, Huntington SF. Clin Lymphoma Myeloma Leuk. 2024 Oct; 2024 Jun 4. PMID: 39034204.
• Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma.McNamara B, Greenman M, Bellone S, Santin LA, Demirkiran C, Mutlu L, Hartwich TMP, Yang-Hartwich Y, Ratner E, Schwartz PE, Santin AD. Gynecol Oncol. 2024 Oct; 2024 Jul 8. PMID: 38981151.
• Classification and Risk Factors for Surgical Site Infections in Radical Cystectomy: A 16-Year Analysis.Lokeshwar SD, Choksi AU, Smani S, Ip KL, Javier-DesLoges JF, Rahman SN, Leapman MS, Martin TV, Hesse DG. Surg Infect (Larchmt). 2024 Oct; 2024 Jul 3. PMID: 38959160.
• Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2.Mutlu L, McNamara B, Bellone S, Manavella DD, Demirkiran C, Greenman M, Verzosa MSZ, Buza N, Hui P, Hartwich TMP, Harold J, Yang-Hartwich Y, Zipponi M, Altwerger G, Ratner E, Huang GS, Clark M, Andikyan V, Azodi M, Schwartz PE, Santin AD. Clin Exp Metastasis. 2024 Oct; 2024 Jun 22. PMID: 38909139.
• Changes in Facility Share of Medicaid-insured Patients With Urologic Cancers Following Implementation of the Patient Protection and Affordable Care Act.Demkowicz PC, Buck MB, Nie J, Marks VA, Wheeler SB, Dinan MA, Gross CP, Leapman MS. Urology. 2024 Oct; 2024 Jun 18. PMID: 38901803.
• Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy.Diaz GM, Webb LT, Rabil MJ, Lokeshwar SD, Choksi AU, Leapman MS, Sprenkle PC. Curr Urol Rep. 2024 Oct; 2024 Jun 19. PMID: 38896314.
• Characterization of time toxicity in older patients with metastatic breast cancer.Atre SY, Soulos PR, Kuderer NM, Gross CP, Baum LVM, Dinan MA, Lustberg MB. Breast Cancer Res Treat. 2024 Oct; 2024 May 31. PMID: 38816556.
• Predisposing, Enabling, and Need Factors Driving Palliative Care Use in Head and Neck Cancer.Fereydooni S, Valdez C, William L, Malik D, Mehra S, Judson B. Otolaryngol Head Neck Surg. 2024 Oct; 2024 May 26. PMID: 38796734.
• Trends in breast cancer specific death by clinical stage at diagnoses between 2000-2017.Marczyk M, Kahn A, Silber A, Rosenblit M, Digiovanna MP, Lustberg M, Pusztai L. J Natl Cancer Inst. 2024 Sep 30; 2024 Sep 30. PMID: 39348186.
• Charting the metabolic biogeography of the colorectum in cancer: challenging the right sided versus left sided classification.Jain A, Morris MT, Berardi D, Arora T, Domingo-Almenara X, Paty PB, Rattray NJW, Kerekes D, Lu L, Khan SA, Johnson CH. Mol Cancer. 2024 Sep 28; 2024 Sep 28. PMID: 39342363.
• Editorial for the themed issue: Addressing the dual challenges of opioid use disorder and chronic pain in the context of the opioid crisis.Sofuoglu M, MacLean RR, De Aquino JP. Br J Clin Pharmacol. 2024 Sep 27; 2024 Sep 27. PMID: 39340184.
• Sociodemographic disparities in prostate cancer imaging.Sundaresan V, Lokeshwar S, Sutherland R, Sohoni N, Golos A, Ajjawi I, Leapman M. Abdom Radiol (NY). 2024 Sep 26; 2024 Sep 26. PMID: 39325212.
• Integrated stepped alcohol treatment with contingency management for unhealthy alcohol use among people with HIV: A randomized controlled trial.Edelman EJ, Dziura J, Deng Y, DePhilippis D, Ferguson T, Brown S, Marconi VC, Goetz MB, Rodriguez-Barradas MC, Simberkoff MS, Molina PE, Weintrob AC, Maisto SA, Paris M, Justice AC, Bryant KJ, Fiellin DA. J Acquir Immune Defic Syndr. 2024 Sep 25; 2024 Sep 25. PMID: 39321757.
• Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015-2017 vs 2017-2019.Brouwer AF, Jeon J, Jimenez-Mendoza E, Land SR, Holford TR, Friedman AS, Tam J, Mistry R, Levy DT, Meza R. Tob Control. 2024 Sep 25; 2024 Sep 25. PMID: 36977570.
• Barriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017.Hansen AP, Wilkinson MM, Niesobecki S, Rutz H, Meek JI, Niccolai L, Hinckley AF, Hook S. J Public Health Manag Pract. 2024 Sep 24; 2024 Sep 24. PMID: 39321400.
• Integrating the symptom experience and coping in patients with stage I-III breast cancer in China: A qualitative study.Liang M, Xiong Y, Zhu S, Wang Y, Knobf MT, Ye Z. Eur J Oncol Nurs. 2024 Sep 21; 2024 Sep 21. PMID: 39406178.
• Understanding Barriers and Facilitators to Disaster Preparedness in Federally Qualified Health Centers in the United States: A Mixed Methods Study.Hassan S, Wiciak M, Escobar K, González Montalvo MDM, Richards T, Villanueva H, Ortiz J, Evans DP, Nunez-Smith M. Disaster Med Public Health Prep. 2024 Sep 18; 2024 Sep 18. PMID: 39291834.
• Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN. BMC Public Health. 2024 Sep 18; 2024 Sep 18. PMID: 39289635.
• Strength of Evidence Underlying the CMS-FDA Parallel Review of Comprehensive Genomic Profiling Tests in the Cancer Setting.Stackland S, Schnabel D, Dinan M, Presley CJ, Gross CP. J Natl Cancer Inst. 2024 Sep 18; 2024 Sep 18. PMID: 39288939.
• Building Frontline Capability for Shared Decision-Making (SDM) in a Major Academic Oncology Center Caring for People With Non-Small Cell Lung Cancer: Performance Outcomes of a SDM Simulation Training Program.Alexander CC, Hakim H, Rudell E, Ingram M, Agrawal T, Peterson P, Davies M, Adelson K, Oliver BJ. Perm J. 2024 Sep 16; 2024 Sep 13. PMID: 39269220.